News
Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than ...
Stocks rose Thursday following better-than-expected U.S. retail sales and a decline in jobless claims.These stocks were making moves Thursday:Lucid Group jumped 35% after the luxury-vehicle maker ...
The company will pause several gene therapy development programs, for which it intends to seek partners and other strategic alternatives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results